Journal article icon

Journal article

Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites

Abstract:

Background

Increasing access to essential respiratory medicines and influenza vaccination has been a priority for over three decades. Their use remains low in low- and middle-income countries (LMICs), where little is known about factors influencing use, or about the use of influenza vaccination for preventing respiratory exacerbations.

Methods

We estimated rates of regular use of bronchodilators, inhaled corticosteroids and influenza vaccine, and predictors for use...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.5588/ijtld.14.0263

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Nuffield Department of Population Health, Clinical Trial Service Unit
Role:
Author
Expand authors...
AstraZeneca More from this funder
Boehringer-Ingelheim More from this funder
Expand funders...
Publisher:
IngentaConnect Publisher's website
Journal:
International Journal of Tuberculosis and Lung Disease Journal website
Volume:
19
Issue:
1
Pages:
21-30
Publication date:
2015-01-05
DOI:
EISSN:
1815-7920
ISSN:
1027-3719
URN:
uuid:c15b28ed-a74f-44d2-8d1e-984b2ec457cf
Source identifiers:
566472
Local pid:
pubs:566472

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP